Yeganeh Reuven
Director
SaleAlert
- Shares
- 530,000
- Price
- $5.00
- Value
- $2,650,000
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•4 filings
PHGE
BiomX Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$33,322,000
1 distinct insiders
Highlighted alerts
7
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get PHGE insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
PHGE overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
15
Raw transactions
Everything returned by the filing
7
Voluntary view
P/S trades after deterministic checks
0
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 530,000
- Price
- $5.00
- Footnotes
- 4
Represents shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer received upon conversion of the Issuer's Series Y Convertible Preferred Stock, par value $0.0001 per share, held by the Reporting Person at a conversion price equal to $2.00 per share. The reported securities are directly owned by Pyu Pyu Capital, LLC ("Pyu Pyu") and may be deemed to be beneficially owned by the Reporting Person as sole member of Pyu Pyu. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The shares of Common Stock were sold in private transactions at a price of $5.00 per share. The warrants were sold in private transactions at the specified price per warrant share.
Raspberry interpretation
Eligible voluntary-market alert
Reason: voluntary_market_trade.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Yeganeh Reuven
Director
SaleAlert
- Shares
- 450,000
- Price
- $5.00
- Value
- $2,250,000
Yeganeh Reuven
Director
SaleAlert
- Shares
- 1,700,000
- Price
- $4.76
- Value
- $8,092,000
Yeganeh Reuven
Director
SaleAlert
- Shares
- 2,000,000
- Price
- $5.24
- Value
- $10,480,000
Yeganeh Reuven
Director
SaleAlert
- Shares
- 1,300,000
- Price
- $5.00
- Value
- $6,500,000
Yeganeh Reuven
Director
SaleAlert
- Shares
- 370,000
- Price
- $5.00
- Value
- $1,850,000
Yeganeh Reuven
Director
SaleAlert
- Shares
- 300,000
- Price
- $5.00
- Value
- $1,500,000
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Yeganeh Reuven Director | Sale | 530,000 | $5.00 | $2,650,000 | |
| Mar 16, 2026 | Yeganeh Reuven Director | Sale | 450,000 | $5.00 | $2,250,000 | |
| Mar 16, 2026 | Yeganeh Reuven Director | Sale | 1,700,000 | $4.76 | $8,092,000 | |
| Mar 16, 2026 | Yeganeh Reuven Director | Sale | 2,000,000 | $5.24 | $10,480,000 | |
| Mar 16, 2026 | Yeganeh Reuven Director | Sale | 1,300,000 | $5.00 | $6,500,000 | |
| Mar 13, 2026 | Yeganeh Reuven Director | Sale | 370,000 | $5.00 | $1,850,000 | |
| Mar 12, 2026 | Yeganeh Reuven Director | Sale | 300,000 | $5.00 | $1,500,000 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.